Might axial myofascial properties and biomechanical mechanisms be relevant to ankylosing spondylitis and axial spondyloarthritis?

Abstract:

:Ankylosing spondylitis and axial spondyloarthropathy have characteristic age- and sex-specific onset patterns, typical entheseal lesions, and marked heritability, but the integrative mechanisms causing the pathophysiological and structural alterations remain largely undefined. Myofascial tissues are integrated in the body into webs and networks which permit transmission of passive and active tensional forces that provide stabilizing support and help to control movements. Axial myofascial hypertonicity was hypothesized as a potential excessive polymorphic trait which could contribute to chronic biomechanical overloading and exaggerated stresses at entheseal sites. Such a mechanism may help to integrate many of the characteristic host, pathological, and structural features of ankylosing spondylitis and axial spondyloarthritis. Biomechanical stress and strain were recently documented to correlate with peripheral entheseal inflammation and new bone formation in a murine model of spondyloarthritis. Ankylosing spondylitis has traditionally been classified by the modified New York criteria, which require the presence of definite radiographic sacroiliac joint lesions. New classification criteria for axial spondyloarthritis now include patients who do not fulfill the modified New York criteria. The male-to-female sex ratios clearly differed between the two patient categories - 2:1 or 3:1 in ankylosing spondylitis and 1:1 in non-radiographic axial spondyloarthritis - and this suggests a spectral concept of disease and, among females, milder structural alterations. Magnetic resonance imaging of active and chronic lesions in ankylosing spondylitis and axial spondyloarthritis reveals complex patterns, usually interpreted as inflammatory reactions, but shows similarities to acute degenerative disc disease, which attributed to edema formation following mechanical stresses and micro-damage. A basic question is whether mechanically induced microinjury and immunologically mediated inflammatory mechanisms operate in both ankylosing spondylitis and degenerative disc disease but differ in relative degrees. The hypothesized biomechanical properties raised in this commentary require documentation of their association with the onset risk and course of ankylosing spondylitis and axial spondyloarthritis. If particular subsets of ankylosing spondylitis and axial spondyloarthritis patients are confirmed to have altered axial myofascial properties, their biological basis and underlying biomechanical mechanisms promise to become clarified. Understanding how biomechanical and physical properties can affect symptomatic and structural manifestations of these disorders could also improve their management.

journal_name

Arthritis Res Ther

authors

Masi AT

doi

10.1186/ar4532

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

107

issue

2

eissn

1478-6354

issn

1478-6362

pii

ar4532

journal_volume

16

pub_type

杂志文章
  • Stratifying primary Sjögren's syndrome: killers in the balance?

    abstract::The article by Seror et al. in Arthritis Research & Therapy reports data from the 15 French patients in the open-label BELISS (Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome, NCT01160666) study of belimumab in primary Sjögren's syndrome. The study identifies that higher baseline levels of...

    journal_title:Arthritis research & therapy

    pub_type: 社论

    doi:10.1186/s13075-015-0878-9

    authors: Bowman SJ,Fisher BA

    更新日期:2015-12-07 00:00:00

  • Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?

    abstract::Glucosamine in its acetylated form is a natural constituent of some glycosaminoglycans (for example, hyaluronic acid and keratan sulfate) in the proteoglycans found in articular cartilage, intervertebral disc and synovial fluid. Glucosamine can be extracted and stabilized by chemical modification and used as a drug or...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/ar3657

    authors: Henrotin Y,Mobasheri A,Marty M

    更新日期:2012-01-30 00:00:00

  • Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.

    abstract:INTRODUCTION:Recent advances suggest that the cellular redox state may play a significant role in the progression of fibrosis in systemic sclerosis (SSc). Another, and as yet poorly accounted for, feature of SSc is its overlap with thyroid abnormalities. Previous reports demonstrate that hypothyroidism reduces oxidant ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4300

    authors: Bagnato G,Bitto A,Irrera N,Pizzino G,Sangari D,Cinquegrani M,Roberts W,Atteritano M,Altavilla D,Squadrito F,Bagnato G,Saitta A

    更新日期:2013-09-16 00:00:00

  • Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009.

    abstract:INTRODUCTION:Gouty arthritis (gout) is primarily cared for in ambulatory care settings. Although the prevalence of gout in the US is thought to be increasing, there have been few data on this as well as temporal changes in gout medication use. METHODS:We analyzed annual visit and drug utilization data from national sa...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4370

    authors: Krishnan E,Chen L

    更新日期:2013-11-06 00:00:00

  • Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates interstitial lung disease in SKG mice.

    abstract:BACKGROUND:Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a sometimes life-threatening complication in RA patients. SKG mice develop not only arthritis but also an ILD resembling RA-ILD. We previously reported that tofacitinib, a JAK inhibitor, facilitates the expansion of myeloid-derived suppres...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-019-1963-2

    authors: Sendo S,Saegusa J,Yamada H,Nishimura K,Morinobu A

    更新日期:2019-08-06 00:00:00

  • Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis.

    abstract:INTRODUCTION:The objective was to study immune regulation in a mouse model of rheumatoid arthritis that exhibits considerable heterogeneity of disease activity. METHODS:T-cell receptor transgenic mice, in which nearly all CD4+ T cells recognize a single peptide of type II collagen, were immunized with collagen and obs...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2795

    authors: Lundy SK,Fox DA

    更新日期:2009-01-01 00:00:00

  • Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects.

    abstract:INTRODUCTION:Rheumatoid arthritis (RA) is considered a T cell driven autoimmune disease, therefore, the ability of B cell depleting biologics, e.g., anti-CD20 antibodies, to alleviate RA is unclear. This study examined the proportions of IL-17-secreting lymphocytes in the blood of healthy subjects and RA patients and d...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3541

    authors: Eggleton P,Bremer E,Tarr JM,de Bruyn M,Helfrich W,Kendall A,Haigh RC,Viner NJ,Winyard PG

    更新日期:2011-01-01 00:00:00

  • Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort.

    abstract:INTRODUCTION:Little is known about systemic B-cell activation in early rheumatoid arthritis (RA). We therefore evaluated the serum levels of markers of B-cell activation in patients included in the ESPOIR early arthritis cohort. METHODS:In the ESPOIR early arthritis cohort (at least 2 swollen joints for more than 6 we...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,多中心研究

    doi:10.1186/ar2773

    authors: Gottenberg JE,Miceli-Richard C,Ducot B,Goupille P,Combe B,Mariette X

    更新日期:2009-01-01 00:00:00

  • Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study.

    abstract:BACKGROUND:It is currently impossible to predict the prognosis of patients with juvenile dermatomyositis (JDM). The aim of this study was to find clinical features most strongly associated with outcome variables in JDM as a first step towards tailor-made treatment. METHODS:In a large, prospectively followed, multicent...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s13075-018-1687-8

    authors: van Dijkhuizen EHP,De Iorio M,Wedderburn LR,Deakin CT,JDRG.

    更新日期:2018-08-15 00:00:00

  • Direct transplantation of mesenchymal stem cells into the knee joints of Hartley strain guinea pigs with spontaneous osteoarthritis.

    abstract:INTRODUCTION:Mesenchymal stem cells (MSCs) can differentiate into various connective tissue cells. Several techniques have been used for the clinical application of MSCs in articular cartilage repair; however, there are many issues associated with the selection of the scaffold material, including its ability to support...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3735

    authors: Sato M,Uchida K,Nakajima H,Miyazaki T,Guerrero AR,Watanabe S,Roberts S,Baba H

    更新日期:2012-02-07 00:00:00

  • Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients.

    abstract:INTRODUCTION:Systemic lupus erythematosus (SLE) patients have lower bone mineral density and increased fracture risk when compared with healthy individuals, due to distinct factors and mechanisms. Bone remodeling is a tightly orchestrated process dependent on several factors, including the balance between receptor acti...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,多中心研究

    doi:10.1186/ar3500

    authors: Carmona-Fernandes D,Santos MJ,Perpétuo IP,Fonseca JE,Canhão H

    更新日期:2011-01-01 00:00:00

  • Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance.

    abstract:INTRODUCTION:Rheumatoid arthritis (RA) frequently involves the loss of tolerance to citrullinated antigens, which may play a role in pathogenicity. Citrullinated fibrinogen is commonly found in inflamed synovial tissue and is a frequent target of autoantibodies in RA patients. To obtain insight into the B-cell response...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3205

    authors: van Beers JJ,Raijmakers R,Alexander LE,Stammen-Vogelzangs J,Lokate AM,Heck AJ,Schasfoort RB,Pruijn GJ

    更新日期:2010-01-01 00:00:00

  • The effectiveness of low-level laser therapy for nonspecific chronic low back pain: a systematic review and meta-analysis.

    abstract:BACKGROUND:In recent decades, low-level laser therapy (LLLT) has been widely used to relieve pain caused by different musculoskeletal disorders. Though widely used, its reported therapeutic outcomes are varied and conflicting. Results similarly conflict regarding its usage in patients with nonspecific chronic low back ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,meta分析,评审

    doi:10.1186/s13075-015-0882-0

    authors: Huang Z,Ma J,Chen J,Shen B,Pei F,Kraus VB

    更新日期:2015-12-15 00:00:00

  • A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients.

    abstract:INTRODUCTION:Anti-malarial drug artesunate can suppress inflammation and prevent cartilage and bone destruction in collagen-induced arthritis model in rats-suggesting it may be a potent drug for rheumatoid arthritis (RA) therapy. We aimed to investigate its effect on the invasive property of fibroblast-like synoviocyte...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-019-1935-6

    authors: Ma JD,Jing J,Wang JW,Yan T,Li QH,Mo YQ,Zheng DH,Gao JL,Nguyen KA,Dai L

    更新日期:2019-06-24 00:00:00

  • Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors.

    abstract:INTRODUCTION:The interaction between the immune and skeletal systems is evidenced by the bone loss observed in autoimmune diseases such as rheumatoid arthritis. In this paper we describe a new mechanism by which the immune cytokine IL-17A directly affects osteoclastogenesis. METHODS:Human CD14+ cells were isolated fro...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2936

    authors: Adamopoulos IE,Chao CC,Geissler R,Laface D,Blumenschein W,Iwakura Y,McClanahan T,Bowman EP

    更新日期:2010-01-01 00:00:00

  • Different expression of β subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes.

    abstract:BACKGROUND:Fibroblast-like synoviocytes (FLS) in rheumatoid arthritis (RA-FLS) contribute to joint inflammation and damage characteristic of the disease. RA-FLS express KCa1.1 (BK, Slo1, MaxiK, KCNMA1) as their major plasma membrane potassium channel. Blocking KCa1.1 reduces the invasive phenotype of RA-FLS and attenua...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-016-1003-4

    authors: Pethő Z,Tanner MR,Tajhya RB,Huq R,Laragione T,Panyi G,Gulko PS,Beeton C

    更新日期:2016-05-10 00:00:00

  • Regenerative potential of human muscle stem cells in chronic inflammation.

    abstract:INTRODUCTION:Chronic inflammation is a profound systemic modification of the cellular microenvironment which could affect survival, repair and maintenance of muscle stem cells. The aim of this study was to define the role of chronic inflammation on the regenerative potential of satellite cells in human muscle. METHODS...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3540

    authors: Duijnisveld BJ,Bigot A,Beenakker KG,Portilho DM,Raz V,van der Heide HJ,Visser CP,Chaouch S,Mamchaoui K,Westendorp RG,Mouly V,Butler-Browne GS,Nelissen RG,Maier AB

    更新日期:2011-01-01 00:00:00

  • Baseline JAK phosphorylation profile of peripheral blood leukocytes, studied by whole blood phosphospecific flow cytometry, is associated with 1-year treatment response in early rheumatoid arthritis.

    abstract:BACKGROUND:We found recently that baseline signal transducer and activator of transcription 3 phosphorylation in peripheral blood CD4+ T cells of patients with early rheumatoid arthritis (RA) is associated with treatment response to synthetic disease-modifying antirheumatic drugs (DMARDs). This prompted us to study the...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-017-1278-0

    authors: Kuuliala K,Kuuliala A,Koivuniemi R,Kautiainen H,Repo H,Leirisalo-Repo M

    更新日期:2017-04-11 00:00:00

  • Immediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay.

    abstract:INTRODUCTION:Autoantibodies against mutated and citrullinated vimentin (MCV) represent a novel diagnostic marker for rheumatoid arthritis (RA). Recently, an increased sensitivity for anti-MCV compared to autoantibodies against cyclic citrullinated peptides (anti-CCP2) was shown in cohorts of patients with early RA and ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3057

    authors: Renger F,Bang H,Feist E,Fredenhagen G,Natusch A,Backhaus M,Burmester GR,Egerer K

    更新日期:2010-01-01 00:00:00

  • The association of low complement with disease activity in systemic sclerosis: a prospective cohort study.

    abstract:BACKGROUND:In some rheumatic diseases such as systemic lupus erythematosus (SLE), low serum complement ('hypocomplementaemia') is a feature of active disease. However, the role of hypocomplementaemia in systemic sclerosis (SSc) is unknown. We sought to determine the frequency, clinical associations and relationship to ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-016-1147-2

    authors: Esposito J,Brown Z,Stevens W,Sahhar J,Rabusa C,Zochling J,Roddy J,Walker J,Proudman SM,Nikpour M

    更新日期:2016-10-22 00:00:00

  • The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.

    abstract:INTRODUCTION:We designed OP3-4 (YCEIEFCYLIR), a cyclic peptide, to mimic the soluble osteoprotegerin (OPG), and was proven to bind to RANKL (receptor activator of NF-κB ligand), thereby inhibiting osteoclastogenesis. We recently found that another RANKL binding peptide, W9, could accelerate bone formation by affecting ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-015-0753-8

    authors: Kato G,Shimizu Y,Arai Y,Suzuki N,Sugamori Y,Maeda M,Takahashi M,Tamura Y,Wakabayashi N,Murali R,Ono T,Ohya K,Mise-Omata S,Aoki K

    更新日期:2015-09-12 00:00:00

  • Clinical value of whole-body PET/CT in patients with active rheumatic diseases.

    abstract::Advanced imaging techniques may enable early diagnosis and monitoring of therapy in various rheumatic diseases. To prevent irreversible tissue damage, inflammatory rheumatic disease must be diagnosed and treated in pre-clinical stages, requiring highly sensitive detection techniques. Positron emission tomography (PET)...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章,评审

    doi:10.1186/s13075-014-0423-2

    authors: Yamashita H,Kubota K,Mimori A

    更新日期:2014-01-01 00:00:00

  • The role of aldosterone blockade in murine lupus nephritis.

    abstract:BACKGROUND:The purpose of this study was to examine the effect of aldosterone receptor blockade on the immunopathogenesis and progression of nephritis in the (NZB x NZW) F1 murine lupus model. METHODS:Female NZB/W F1 mice (11 weeks old) were treated daily with 25 or 50 mg/kg oral spironolactone or vehicle. Proteinuria...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2353

    authors: Monrad SU,Killen PD,Anderson MR,Bradke A,Kaplan MJ

    更新日期:2008-01-01 00:00:00

  • Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs.

    abstract:INTRODUCTION:Biological markers specifically reflecting pathological processes may add value in the assessment of inter-individual variations in the course of rheumatoid arthritis (RA). The current study was undertaken to investigate whether baseline serum levels of the chemokine CXCL13 might predict clinical and ultra...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3742

    authors: Bugatti S,Manzo A,Benaglio F,Klersy C,Vitolo B,Todoerti M,Sakellariou G,Montecucco C,Caporali R

    更新日期:2012-02-15 00:00:00

  • Sizing up stability: combination therapy with Apo-AI peptide mimetics and statins in systemic lupus erythematosus-mediated atherosclerosis.

    abstract::In a study published recently in Arthritis Research & Therapy, Woo and colleagues investigated the effects of pravastatin in combination with an apolipoprotein-AI (Apo-AI) mimetic peptide in a mouse model of lupus-accelerated atherosclerosis. Combination treatment resulted in a significant decrease in systemic inflamm...

    journal_title:Arthritis research & therapy

    pub_type: 评论,社论

    doi:10.1186/ar3115

    authors: Mendez-Fernandez Y,Major A

    更新日期:2010-01-01 00:00:00

  • Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection.

    abstract:INTRODUCTION:Intraarticular administration of autologous conditioned serum (ACS) recently demonstrated some clinical effectiveness in treatment of osteoarthritis (OA). The current study aims to evaluate the in vitro effects of ACS on cartilage proteoglycan (PG) metabolism, its composition and the effects on synovial fl...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar3050

    authors: Rutgers M,Saris DB,Dhert WJ,Creemers LB

    更新日期:2010-01-01 00:00:00

  • Toll-like receptors and innate immune responses in systemic lupus erythematosus.

    abstract::A series of discoveries over the past several years has provided a new paradigm for understanding autoimmunity in systemic lupus erythematosus. The discoveries of pattern recognition receptors and of how these receptors can be recruited into autoimmune responses underpin this paradigm. The implications of these observ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar2321

    authors: Lafyatis R,Marshak-Rothstein A

    更新日期:2007-01-01 00:00:00

  • Rheumatoid arthritis patients are not at increased risk for 30-day cardiovascular events, infections, or mortality after total joint arthroplasty.

    abstract:INTRODUCTION:Serious infection, cardiovascular disease, and mortality are increased in rheumatoid arthritis (RA). Whether RA affects the risk for these complications after total joint arthroplasty (TJA) is unknown, we hypothesize that it does. We compared the occurrence of 30-day postoperative complications and mortali...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4385

    authors: Michaud K,Fehringer EV,Garvin K,O'Dell JR,Mikuls TR

    更新日期:2013-01-01 00:00:00

  • Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.

    abstract:BACKGROUND:Systemic sclerosis (SSc) is characterized by early vascular abnormalities and subsequent fibroblast activation to myofibroblasts, leading to fibrosis. Recently, endothelial-to-mesenchymal transition (EndoMT), a complex biological process in which endothelial cells lose their specific markers and acquire a me...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/s13075-016-1122-y

    authors: Corallo C,Cutolo M,Kahaleh B,Pecetti G,Montella A,Chirico C,Soldano S,Nuti R,Giordano N

    更新日期:2016-10-06 00:00:00

  • Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency.

    abstract:INTRODUCTION:We previously demonstrated that a single-chain fragment variable (scFv) specific to collagen type II (CII) posttranslationally modified by reactive oxygen species (ROS) can be used to target anti-inflammatory therapeutics specifically to inflamed arthritic joints. The objective of the present study was to ...

    journal_title:Arthritis research & therapy

    pub_type: 杂志文章

    doi:10.1186/ar4613

    authors: Hughes C,Sette A,Seed M,D'Acquisto F,Manzo A,Vincent TL,Lim NH,Nissim A

    更新日期:2014-07-16 00:00:00